ATLAS / Macro Radar / Reporting / SPRY

ARS Pharmaceuticals, Inc. (SPRY) reporting calendar

ARS Pharmaceuticals, Inc. files periodic reports with the SEC as SPRY on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001193125-26-225142
10-K31 Dec 20259 Mar 202668 days0001193125-26-097478
10-Q30 Sep 202510 Nov 202541 days0001193125-25-273111
10-Q30 Jun 202513 Aug 202544 days0000950170-25-107618
10-Q31 Mar 202514 May 202544 days0000950170-25-070900
10-K31 Dec 202420 Mar 202579 days0000950170-25-042320
10-Q30 Sep 202413 Nov 202444 days0000950170-24-125924
10-Q30 Jun 20246 Aug 202437 days0000950170-24-091776
10-Q31 Mar 20249 May 202439 days0000950170-24-056967
10-K31 Dec 202321 Mar 202481 days0000950170-24-034689
10-Q30 Sep 20239 Nov 202340 days0000950170-23-061996
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041310
10-Q31 Mar 202315 May 202345 days0000950170-23-021997
10-K31 Dec 202223 Mar 202382 days0000950170-23-009491
10-Q30 Sep 20222 Nov 202233 days0000950170-22-021234
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016840
10-Q31 Mar 202212 May 202242 days0000950170-22-009694
10-K31 Dec 202131 Mar 202290 days0000950170-22-005202
10-Q30 Sep 202110 Nov 202141 days0000950170-21-004106
10-Q30 Jun 202112 Aug 202143 days0000950170-21-001379
10-Q31 Mar 202113 May 202143 days0001193125-21-160519
10-K31 Dec 202029 Mar 202188 days0001193125-21-098283

Source: SEC EDGAR company submissions for CIK 0001671858. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.